Helix BioPharma Corp. We are focused on the development and commercialization of innovative medicines in the areas of cancer prevention and treatment. The Company also evaluates its products for other potential therapeutic applications beyond oncology, and works to expand upon its product development pipeline through its in-house R&D efforts and potential mergers and acquisition activities. Our core business strategy is to commercialize the drug products we develop on a royalty-bearing basis via third-party licensing arrangements.